The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
MRI contrast agents: Basic chemistry and safety
Abstract
Magnetic resonance imaging (MRI) contrast agents are pharmaceuticals used widely in MRI examinations. Gadolinium‐based MRI contrast agents (GBCAs) are by far the most commonly used. To date, nine GBCAs have been commercialized for clinical use, primarily indicated in the central nervous system, vasculature, and whole body. GBCAs primarily lower the T 1 in vivo to create higher signal in T 1‐weighted MRI scans where GBCAs are concentrated. GBCAs are unique among pharmaceuticals, being water proton relaxation catalysts whose effectiveness is characterized by a rate constant known as relaxivity. The relaxivity of each GBCAs depends on a variety of factors that are discussed in terms of both the existing agents and future molecular imaging agents under study by current researchers. Current GBCAs can be divided into four different structural types (macrocyclic, linear, ionic, and nonionic) based on the chemistry of the chelating ligands whose primary purpose is to protect the body from dissociation of the relatively toxic Gd 3+ ion from the ligand. This article discusses how the chemical structure influences inherent and in vivo stability toward dissociation, and how it affects important formulation properties. Although GBCAs have a lower rate of serious adverse events than iodinated contrast agents, they still present some risk. J. Magn. Reson. Imaging 2012;36:1060–1071. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
Caravan, P., Ellison, J. J., McMurry, T. J., & Lauffer, R. B. (1999) · Chemical Reviews · doi:10.1021/cr980440x · Cited by 4,483
Rohrer, M., Bauer, H., Mintorovitch, J., Requardt, M., & Weinmann, H.-J. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000184756.66360.d3 · Cited by 1,682
Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent
Weinmann, H., Brasch, R., Press, W., & Wesbey, G. (1984) · American Journal of Roentgenology · doi:10.2214/ajr.142.3.619 · Cited by 1,231
Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation
Sadowski, E. A., Bennett, L. K., Chan, M. R., Wentland, A. L., Garrett, A. L., Garrett, R. W., & Djamali, A. (2007) · Radiology · doi:10.1148/radiol.2431062144 · Cited by 1,018
ACR Guidance Document for Safe MR Practices: 2007
Kanal, E., Barkovich, A. J., Bell, C., Borgstede, J. P., Bradley, W. G., Froelich, J. W., Gilk, T., Gimbel, J. R., Gosbee, J., Kuhni-Kaminski, E., et al. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1616 · Cited by 787
Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C
Frenzel, T., Lengsfeld, P., Schirmer, H., Hütter, J., & Weinmann, H.-J. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e3181852171 · Cited by 539
The Design of Molecular Hosts, Guests, and Their Complexes
Cram, D. J. (1988) · Science · doi:10.1126/science.3283937 · Cited by 511
MS-325: albumin-targeted contrast agent for MR angiography.
Lauffer, R. B., Parmelee, D. J., Dunham, S. U., Ouellet, H. S., Dolan, R. P., Witte, S., McMurry, T. J., & Walovitch, R. C. (1998) · Radiology · doi:10.1148/radiology.207.2.9577506 · Cited by 457
Laurent, S., Elst, L. V., & Muller, R. N. (2006) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.100 · Cited by 441
The relationship between thermodynamics and the toxicity of gadolinium complexes
Cacheris, W. P., Quay, S. C., & Rocklage, S. M. (1990) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(90)90055-7 · Cited by 436
Cited by
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
Hong, G., Diao, S., Antaris, A. L., & Dai, H. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00008 · Cited by 1,394
Intracranial gadolinium deposition after contrast-enhanced MR imaging
McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Murray, D. L., Thielen, K. R., Williamson, E. E., & Eckel, L. J. (2015) · Radiology · doi:10.1148/radiol.15150025 · Cited by 1,358
Kanda, T., Ishii, K., Kawaguchi, H., Kitajima, K., & Takenaka, D. (2014) · Radiology · doi:10.1148/radiol.13131669 · Cited by 1,339
Kanda, T., Fukusato, T., Matsuda, M., Toyoda, K., Oba, H., Kotoku, J., Haruyama, T., Kitajima, K., & Furui, S. (2015) · Radiology · doi:10.1148/radiol.2015142690 · Cited by 874
Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update
Ramalho, J., Semelka, R. C., Ramalho, M., Nunes, R. H., AlObaidy, M., & Castillo, M. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4615 · Cited by 453
Gadolinium‐based contrast agents: A comprehensive risk assessment
Fraum, T. J., Ludwig, D. R., Bashir, M. R., & Fowler, K. J. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25625 · Cited by 402
Cyclometalated iridium(III) complexes for life science
Caporale, C., & Massi, M. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.02.006 · Cited by 258
Shen, Y., Goerner, F. L., Snyder, C., Morelli, J. N., Hao, D., Hu, D., Li, X., & Runge, V. M. (2015) · Investigative Radiology · doi:10.1097/rli.0000000000000132 · Cited by 257
Self-citationGhasemian, M., Kazeminava, F., Naseri, A., Mohebzadeh, S., Abbaszadeh, M., Kafil, H. S., & Ahmadian, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115328 · Cited by 55
Adaptive Learning in AI Agents for the Metaverse: The ALMAA Framework
Xia, Y., Shin, S.-Y., & Lee, H.-A. (2024) · Applied Sciences · doi:10.3390/app142311410 · Cited by 15
Metadata
- Authors
- Hao, D., Ai, T., Goerner, F., Hu, X., Runge, V. M., & Tweedle, M.
- Venue
- Journal of Magnetic Resonance Imaging
- Publisher
- Wiley
- Published
- 2012-10-22
- Volume
- 36
- Issue
- 5
- Pages
- 1060-1071
- ISSN
- 1053-1807 (ISSN-L)
- 1522-2586
- OpenAlex
- W2111481358
- Cited by
- 336
- References
- 37
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.